anti inflammatory effects of glp 1 Anti-inflammatory glucagon-like peptide-1 (GLP-1)-based drugs GLP-1 Drugs: For Multiple Chronic
Description
Could the diabetes drug, Mounjaro, work even better for weight loss than the popular medications, Ozempic and Wegovy

This isn't medical advice, it's observational data from wearables at scale

The result is a single injectable solution containing both the peptide and the vitamin

Surgical procedures: Inform your surgical and anaesthetic teams about GLP-1 receptor agonist use before any planned procedures, as these medications may affect gastric emptying and potentially increase aspiration risk

In response to the observed weight loss effects during clinical trials, the FDA approved a higher-dose version of Ozempic, known as Wegovy, in 2021 for weight management
